Oral antibiotic prophylaxis in patients with cancer: A double-blind randomized placebo-controlled trial

The Journal of Pediatrics

Volumn 102, Issue 1, 1983, Pages 125-133

  Pizzo, Philip A ^a,b,c   Robichaud, Kathleen J ^a,b,c   Edwards, Brenda K ^a,b,c   Schumaker, Cathie ^a,b,c   Kramer, Barnett S ^a,b,c   Johnson, Alicia ^a,b,c  

^a Pediatric Oncology Branch   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CYTOSTATIC AGENT; ERYTHROMYCIN;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; CANCER; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG COMPARISON; DRUG THERAPY; ERYTHEMA; FEVER; GRANULOCYTOPENIA; HUMAN; IMMUNE DEFICIENCY; INFECTION; INTOXICATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PREVENTION; PROPHYLAXIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SKIN TOXICITY; THERAPY;

ADOLESCENT; ADULT; AGRANULOCYTOSIS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; FEMALE; FEVER; HUMANS; INFANT; LEUKEMIA; LYMPHOMA; MALE; NEOPLASMS; PATIENT COMPLIANCE; RANDOM ALLOCATION; SULFAMETHOXAZOLE; TRIMETHOPRIM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0020659195     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(83)80310-2     Document Type: Article

References (36)

1. Origin of infection in acute nonlymphocytic leukemia: Significance of hospital acquisition of potential pathogens
2. Infection prevention during profound granulocytopenia: New approaches to alimentary canal microbial suppression
3. Infectious complications in the child with cancer. III
4. Infection prevention during granulocytopenia
5. The value of protective isolation in preventing nosocomial infections in high-risk patients
6. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis
7. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients
8. Colonization resistance of the digestive tract in mice during systemic antibiotic treatment
9. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract
10. Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients
11. Selective antimicrobial modulation of human microbial flora: Infection prevention with decreased host defense mechanisms by selective elimation of potentially pathogenic bacteria
12. Fever in the patient with cancer: A prospective study of 1001 episodes
13. Erythromycin: A review of its uses in pediatric practice
14. Trimethoprim-sulfamethoxazole in the United States
15. The randomization and stratification of patients to clinical trials
16. Prevention of infection by trimethoprim sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic Leukemia
17. A comparison of trimethoprim sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia
18. Prophylactic trimethropim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: A control trial
19. Cotrimoxazole and reduction of risk of infection in neutropenic patients: A progress report
20. A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients
21. Protected environment and prophylactic antibiotics: A prospective controlled study of their utility in the therapy of acute leukemia
22. Prophylactic oral antibiotics in the management of acute leukemia
23. Infection prevention in acute nonlymphocytic leukemia: Laminar air flow room reverse isolation with nonabsorbable oral antibiotic prophylaxis
24. Randomized trial of protected environment: Prophylactic antibiotics in 145 adults with acute leukemia
25. Oral non-absorbed antibiotics prevent infection in acute nonlymphoblastic leukemia
26. Hepatic injury in a child caused by trimethoprim-sulfamethoxazole
27. Trimethoprim-sulfamethozazole-induced intrahepatic cholestasis
28. Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary tract infection
29. Comparison of trimethoprim alone with trimethoprim-sulfamethoxazole in the treatment of respiratory and urinary infection with particular reference to selection of trimethoprim resistance
30. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: Isolation of resistance plasmids from strains of Enterobactereiaceae causing bacteremia
31. Pancytopenia in an infant associated with sulfamethoxazole-trimethoprim therapy
32. Trimethoprim and sulfamethoxazole inhibition of haematopoeisis in vitro
33. Effect of trimethoprim-sulfamethoxazole on hematological recovery after total body irradiation and autologous marrow infusion in dogs
34. Influence of co-trimoxazole on methotrexate pharmacokinetics in children with acute lymphoblastic leukemia